eHealth-based Cardiac Rehabilitation in Post-myocardial Infarction Patients

NCT05689385 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-08-28

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to compare the effect of eHealth-based cardiac rehabilitation with the effect of usual care on exercise capacity and qualify of life in patients after myocardial infarction.

Conditions

Interventions

OTHER

eHealth-based cardiac rehabilitation

The 12-wk case manager-led eHCR program includes: 1. Individualized exercise prescription according to the results of cardiopulmonary exercise test. 2. At least one session of in-person physical therapy to familiarize participants with the process of exercise training before the initiation of telerehabilitation. 3. Telerehabilitation: a 30-minute moderate aerobic exercise training with remote monitoring and instruction using video conferencing. (Frequency: twice per week in the first 4 weeks, once per week in the 5th-8th week, once every 2 weeks in the 9th-12th week) 4. Additional self-exercise to achieve the target volume of 150-minute moderate aerobic exercise and 2 sessions of resistance training per week. 5. Patient education for secondary prevention delivered regularly via a communication app on the smartphone. 6. Weekly follow-up call from a case manager via phone call or communication app.

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Hung-Jui Chuang, MD · Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-20
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05689385 on ClinicalTrials.gov